41 completed, 3 unknown, 3 withdrawn, 1 active not recruiting. 51 Phase 1, 12 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 51 | Completed 41, Unknown 3, Withdrawn 3, Active not recruiting 1, Not yet recruiting 1, Recruiting 1, Terminated 1 |
| Phase 2 | 12 | Completed 8, Unknown 3, Withdrawn 1 |
Follow Gels: new trials by email Literature Review of Gels trials Research Report on Gels
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Photodynamic Therapy For Onychomycosis ALA 10% gel, PDT, Urea - Onychomycosis of Toenail | Phase 1 | Active not recruiting | The University of Texas Health Science Center, Houston | 5 | 2026-08-10 | 2026-10-06 |
| Effect of an Experimental Cannabidiol Gel on Tooth Sensitivity Potassium nitrate and sodium fluoride, Cannabidiol (CBD) Gel, Natrosol 4% Gel - Dentin Sensitivity | Phase 1 | Not yet recruiting | Universidade Federal do Para | 75 | 2025-07-25 | 2025-06-18 |
| Targeted Investigation of Microbiome 2 Treat Atopic Dermatitis (TIME-2) ShA9 Topical Gel, Hydrocortisone Ointment, Clobetasol Ointment - Atopic Dermatitis | Phase 1 | Recruiting | National Institute of Allergy and Infectious Diseases (NIAID) | 86 | 2025-05-22 | 2026-07-02 |
| Comparison of Diclofenac Systemic Exposure From Two Different Products (AMZ001 and Diclofenac Diethylammonium 1.16% Gel) in Healthy Participants After Repeated Topical Administrations for 7 Days. Diclofenac sodium gel, Diclofenac diethylamine 1.16% gel - Healthy Volunteer | Phase 1 | Completed | Amzell | 34 | 2024-11-29 | 2026-01-06 |
| Comparison Between the Effect of Aloe Vera and Benzydamine Hydrochloride Mouth Gel on Prevention of Pain and Progression of Radiation-induced Oral Mucositis Aloe vera gel, Benzydamine Hydrochloride 0.15% Oral gel, bioadhesive gel - Radiation Indused Oral Mucositis | Phase 1 / Phase 2 | Completed | Minia University | 30 | 2023-11-01 | 2025-03-06 |
| Study of PTW-002 in Patients With Dominant or Recessive Dystrophic Epidermolysis Bullosa Due to Mutation(s) in Exon 73 of the COL7A1 Gene PTW-002 10 mg/g gel, Placebo - Dystrophic Epidermolysis Bullosa | Phase 1 / Phase 2 | Unknown | Phoenicis Therapeutics | 8 | 2023-04-30 | 2023-03-31 |
| NPC-12G Gel 0.2% Sirolimus PK Bridging Study NPC-12G Gel 0.2%, Rapamune® 2 mg tablet - Bioavailability Study | Phase 1 | Completed | Nobelpharma | 12 | 2019-05-31 | 2020-03-06 |
| Topical Application of Imiquimod Gel at Different Concentrations in Actinic Cheilitis Vehicle Gel Base, Imiquimod 5% gel, Imiquimod 0,05% gel - Actinic Cheilitis | Phase 1 | Terminated | Hospital de Clinicas de Porto Alegre | 49 | 2019-03-23 | 2022-11-22 |
| Pain During Pars Plana Vitrectomy With Sub-tenon Anesthesia Topical lidocaine 2% jelly plus sub-tenon ropivacaine 10% injection, Peribulbar injection - Retinal Disease, Diabetic Retinopathy | Phase 1 / Phase 2 | Completed | University of Sao Paulo | 56 | 2019-01-01 | 2019-11-04 |
| A Study to Characterize Diclofenac's Plasma and Knee Exposure After Application of Diclofenac Gel to the Knee of Subjects With Osteoarthritis That Have a Scheduled Arthroplasty Diclofenac Diethylamine (DDEA) gel, Placebo gel - Pain | Phase 1 | Completed | GlaxoSmithKline | 47 | 2018-07-19 | 2020-02-24 |
| Unripe Banana Peel Powder and Lemongrass Oil in Chronic Ulcer gel combined with lemongrass (Cymbopogon citratus) oil at 0.1% concentration, Collagenase ointment, Gel with 10% peel powder of unripe banana - Chronic Ulcer, Healing Ulcer | Phase 1 | Completed | Universidade do Vale do Sapucai | 25 | 2018-02-02 | 2021-07-15 |
| A Study to Assess the Safety and Tolerability Profile of TR399 in Healthy Volunteers and Erectile Dysfunction Patients TR-399 (5% Vardenafil HCl·3H2O, topical gel) - Erectile Dysfunction | Phase 1 / Phase 2 | Unknown | Tritech Biopharmaceuticals Co., Ltd. | 26 | 2017-03-31 | 2017-11-22 |
| To Evaluate the Therapeutic Equivalence and Safety of Azelaic Acid 15% Topical Gel Azelaic Acid 15% topical gel, Finacea® (azelaic acid) Gel, 15%, Placebo - Rosacea | Phase 1 | Completed | Sun Pharmaceutical Industries, Inc. | 1000 | 2016-07-01 | 2024-04-10 |
| Absorption and Systematic Pharmacokinetics of Topically Applied IDP-120 Gel IDP-120 Gel - Acne | Phase 1 | Completed | Bausch Health Americas, Inc. | 20 | 2016-06-01 | 2017-09-25 |
| Exploratory Study of Efficacy and Safety of Ingenol Mebutate 0.05% Gel for Common Warts on the Hands. ingenol mebutate 0.05% gel - Verruca Vulgaris, Common Warts | Phase 1 | Completed | Neal D. Bhatia, MD | 16 | 2016-04-27 | 2017-07-17 |
| Safety and Pharmacokinetic Study of Oral Maraviroc and Maraviroc 1% Gel in HIV-1 Seronegative Adults Maraviroc 300 mg tablet (PO) and Maraviroc 1% gel (PR and PV) - HIV/AIDS | Phase 1 | Completed | International Partnership for Microbicides, Inc. | 19 | 2015-01-01 | 2017-09-08 |
| MELA Study - Hedonic Study on the Taste of Drugs Crushed in Food: Observational Study Involving 16 Healthy Volunteers Jelly with:Paracetamol, Jelly with Furosemide, Jelly with Levothyroxine sodium salt - Healthy | Phase 1 | Completed | Centre Hospitalier Universitaire de Nice | 16 | 2014-06-01 | 2015-10-07 |
| Safety and Efficacy of PG101 for Dry Eye Syndrome PG101 - Dry Eye Syndrome | Phase 1 / Phase 2 | Completed | Rhodes Pharmaceuticals, L.P. | 72 | 2013-12-01 | 2014-03-05 |
| In Vivo Drug Interaction Pharmacokinetic Study of Tenofovir 1% Gel and Three Commonly Used Vaginal Products Tenofovir 1% gel, Vaginal product - HIV Prevention | Phase 1 | Completed | CONRAD | 101 | 2013-12-01 | 2015-05-22 |
| Use of Topical Lidocaine to Reduce Pain in Preterm Infants Receiving Nasal CPAP Continuous Positive Airway Pressure Lidocaine 2% Gel - Other Preterm Infants | Phase 1 | Completed | Mansoura University Children Hospital | 60 | 2013-10-01 | 2015-04-14 |
Showing 20 of 51. Sign in to see all of them.
Acne Vulgaris (10) · Pain (5) · Keratosis, Actinic (3) · Insulin Resistance (2) · Acquired Immunodeficiency Syndrome (1) · Actinic cheilitis (1) · Altitude Sickness (1) · Dentin Sensitivity (1) · Dermatitis, Atopic (1) · Dermatitis, Phototoxic (1) · Diabetes Mellitus, Type 2 (1) · Diabetic Retinopathy (1) · Dry Eye Syndromes (1) · Eczema (1) · Epidermolysis Bullosa (1)
CONRAD (5) · Allergan (3) · Coria Laboratories, Ltd. (2) · Dr. Reddy's Laboratories Limited (2) · GlaxoSmithKline (2) · Ian McGowan (2) · National Institute of Allergy and Infectious Diseases (NIAID) (2) · Novan, Inc. (2) · Peplin (2) · Pfizer (2) · Sun Pharmaceutical Industries, Inc. (2) · University of Washington (2) · Amzell (1) · Bausch Health Americas, Inc. (1) · Centre Hospitalier Universitaire de Nice (1)
United States (26) · Brazil (4) · Canada (3) · Egypt (2) · France (2) · Germany (2) · Taiwan (2) · Australia (1) · Chile (1) · Dominican Republic (1) · Peru (1) · Puerto Rico (1) · South Africa (1) · United Kingdom (1)
Benoit Girard, MD (2) · Ian McGowan, MD, PhD, FRCP (2) · Jonothan S Dosik, MD (2) · Stephanie T Page, MD, PhD (2) · Abdias Hurtado, MD (1) · Alex Carballo-Dieguez, PhD (1) · Anya Loncaric (1) · Craig Hendrix, MD (1) · Donald Leung, MD, PhD (1)
PMID 24765228, PMID 17342504, PMID 21177791, PMID 23573238, PMID 23842718, PMID 25647729, PMID 25942472, PMID 26227279, PMID 27362788, PMID 27482750, PMID 29793828, PMID 34384282, PMID 39147219, PMID 41869811
U01AI068633 (2), U19AI082637 (2), K23AG027238 (1)